Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,664Revenue $M16,385Net Margin (%)16.6Z-Score5.2
Enterprise Value $M86,287EPS $1.5Operating Margin %17.5F-Score6
P/E(ttm))32.0Cash Flow Per Share $2.8Pre-tax Margin (%)19.3Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %1.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %-5.5Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %165ROA % (ttm)7.5Higher Current Ratio y-yY
Dividend Yield %2.8Insider Buy (3m)0ROE % (ttm)17.9Less Shares Outstanding y-yN
Payout Ratio %89.0Shares Outstanding M1,657ROI % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with BMY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMYVanguard Health Care Fund 2014-06-30 Add0.86%$46.59 - $52.19
($49.29)
$ 51.675%Add 22.96%36,197,961
BMYJoel Greenblatt 2014-06-30 Buy 0.05%$46.59 - $52.19
($49.29)
$ 51.675%New holding, 89363 sh.89,363
BMYRay Dalio 2014-06-30 Sold Out $46.59 - $52.19
($49.29)
$ 51.675%Sold Out0
BMYRonald Muhlenkamp 2014-03-31 Buy 1.9%$48.54 - $56.61
($53.23)
$ 51.67-3%New holding, 212015 sh.212,015
BMYVanguard Health Care Fund 2014-03-31 Add0.73%$48.54 - $56.61
($53.21)
$ 51.67-3%Add 20.35%29,437,761
BMYRay Dalio 2014-03-31 Buy $48.54 - $56.61
($53.23)
$ 51.67-3%New holding, 4428 sh.4,428
BMYGeorge Soros 2014-03-31 Sold Out -0.05%$48.54 - $56.61
($53.23)
$ 51.67-3%Sold Out0
BMYJoel Greenblatt 2014-03-31 Sold Out -0.02%$48.54 - $56.61
($53.23)
$ 51.67-3%Sold Out0
BMYJoel Greenblatt 2013-12-31 Buy 0.02%$46.41 - $53.84
($50.96)
$ 51.671%New holding, 11679 sh.11,679
BMYVanguard Health Care Fund 2013-09-30 Add0.64%$41.32 - $47.53
($43.84)
$ 51.6718%Add 20.26%24,459,861
BMYJean-Marie Eveillard 2013-09-30 Reduce-0.01%$41.32 - $47.53
($43.84)
$ 51.6718%Reduce -75.17%16,520
BMYVanguard Health Care Fund 2013-06-30 Add0.39%$39.68 - $47.68
($43.41)
$ 51.6719%Add 13.32%20,338,461
BMYGeorge Soros 2013-06-30 Buy 0.05%$39.68 - $47.68
($43.41)
$ 51.6719%New holding, 100000 sh.100,000
BMYJean-Marie Eveillard 2013-06-30 Add0.01%$39.68 - $47.68
($43.41)
$ 51.6719%Add 302.66%66,520
BMYRay Dalio 2013-06-30 Sold Out -0.07%$39.68 - $47.68
($43.41)
$ 51.6719%Sold Out0
BMYPrem Watsa 2013-06-30 Sold Out -0.01%$39.68 - $47.68
($43.41)
$ 51.6719%Sold Out0
BMYVanguard Health Care Fund 2013-03-31 Add0.96%$32.59 - $41.19
($36.62)
$ 51.6741%Add 49.53%17,948,561
BMYRay Dalio 2013-03-31 Add0.05%$32.59 - $41.19
($36.62)
$ 51.6741%Add 267.87%181,140
BMYJohn Hussman 2013-03-31 Sold Out -0.64%$32.59 - $41.19
($36.62)
$ 51.6741%Sold Out0
BMYJames Barrow 2013-03-31 Sold Out -0.05%$32.59 - $41.19
($36.62)
$ 51.6741%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BMY Joel Greenblatt 2014-06-3089,3630.010.05New Buy
BMY Vanguard Health Care Fund 2014-06-3036,197,9612.184.6+22.96%
BMY Ronald Muhlenkamp 2014-06-30212,7700.011.8+0.36%
BMY Dodge & Cox 2014-06-3078,92100-0.25%
BMY Mario Gabelli 2014-06-30674,6850.040.17-1.76%
BMY Jean-Marie Eveillard 2014-06-3014,49200-12.28%
BMY Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BMY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cuss Francis MEVP & CSO 2014-09-16Sell63,667$50.771.75view
Caforio GiovanniCOO 2014-09-15Sell26,691$49.873.59view
Caldarella Joseph CSVP & Controller 2014-09-10Sell7,415$51.031.23view
ANDREOTTI LAMBERTOCEO 2014-09-08Sell50,000$51.051.19view
von Autenried PaulSVP, Enterp. Services & CIO 2014-08-19Sell20,000$49.893.55view
Bancroft Charles AEVP & CFO 2014-07-29Sell67,621$51.061.18view
Moed Samuel JSVP, Strat Plan & Analysis 2014-07-28Sell25,752$49.324.74view
Caldarella Joseph CSVP & Controller 2014-03-13Sell9,137$55.2-6.41view
ANDREOTTI LAMBERTOCEO 2014-03-10Sell100,000$55.52-6.95view
Schmukler Louis SPres., Global Mfg. & Supply 2014-03-10Sell8,799$55.81-7.44view

Press Releases about BMY :

    Quarterly/Annual Reports about BMY:

    News about BMY:

    Articles On GuruFocus.com
    Bristol-Myers: Absolute Valuation Model versus Relative Valuation Model Aug 29 2014 
    Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
    UnitedHealth Group Up on Weak Day for the Dow Jul 17 2014 
    Pharma Sector Stocks To Consider For Sustained Returns Jun 25 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    A Look at AstraZeneca’s New Drug on Diabetes May 22 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 21 2014 
    Abbott Capturing Incremental Market Share Mar 18 2014 
    Vanguard Health Care Fund’s Top Five Feb 10 2014 

    More From Our Partners
    Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog Sep 19 2014 - ZACKS

    More From Other Websites
    BRISTOL MYERS SQUIBB CO Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Sep 19 2014
    Bristol-Myers' (BMY) Yervoy Label Expanded in Canada Sep 19 2014
    Merck Enters into Licensing Agreement with Sun Pharma Sep 18 2014
    French cancer immunotherapy specialist OSE Pharma prepares IPO Sep 18 2014
    [$$] Bristol-Myers CEO Sells $2.5 Million in Stock Sep 17 2014
    Bristol-Myers Squibb Announces Dividend Sep 16 2014
    What Ralph Nader Gets Wrong About Big Pharma Sep 16 2014
    Health Canada approves Yervoy® (ipilimumab) for first-line treatment of adults with metastatic... Sep 16 2014
    Video: Gilead OKs Generic Sovaldi To Expand Access Sep 15 2014
    Up and Down the Ladder: The Latest Comings and Goings at FDA, Cardinal Health and… Sep 12 2014
    Insider Trading Alert - BMY, AMBA And MTD Traded By Insiders Sep 11 2014
    Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Global Health Care Conference Sep 11 2014
    Bristol-Myers Needs a Healthy Growth Shot to Justify Its Valuation Sep 09 2014
    Bristol-Myers, Ono Sue Merck Over Cancer-Drug Patent Sep 08 2014
    Bristol-Myers Sues Merck of Patent Infringement on Keytruda Sep 08 2014
    [$$] A New Era in Immuno-Oncology Sep 08 2014
    Bristol-Myers Sues Merck Over a Patent on its new Cancer Drug Sep 08 2014
    J.P. Morgan Biotech Analyst Meacham Exits for New Barclays Gig Sep 08 2014
    Bristol-Myers bulls back for more Sep 08 2014
    Bristol-Myers sues Merck over U.S. immunotherapy patent Sep 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK